Naltrexone Recruiting Phase 3 Trials for Opiate Addiction Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02867124Long-acting Naltrexone for Pre-release Prisoners